157 related articles for article (PubMed ID: 2754697)
21. [N-substituted p-fluorobenzene sulfonamides. 2. Evaluation of antileukemic activity].
Vigorita MG
Boll Chim Farm; 1984 Aug; 123(8):390-3. PubMed ID: 6525249
[No Abstract] [Full Text] [Related]
22. [Compounds with potential antitumor activity. IV. Synthesis and antileukemic activity of 1-aryl-N,N'-di-[2-(1,3,4-thiadiazolyl)]methylenediamine].
Grasso S; Chimirri A; Monforte P; Fenech G; Zappalà M
Farmaco Sci; 1986 Sep; 41(9):713-21. PubMed ID: 3780959
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and P-388 antitumor properties of the four diastereomeric 1-hydroxy-3,4-diaminocyclohexane-Cl2PtII complexes.
Witiak DT; Rotella DP; Wei Y; Filppi JA; Gallucci JC
J Med Chem; 1989 Jan; 32(1):214-7. PubMed ID: 2909734
[TBL] [Abstract][Full Text] [Related]
24. Anthracene-9,10-diones as potential anticancer agents: bacterial mutation studies of amido-substituted derivatives reveal an unexpected lack of mutagenicity.
Venitt S; Crofton-Sleigh C; Agbandje M; Jenkins TC; Neidle S
J Med Chem; 1998 Sep; 41(19):3748-52. PubMed ID: 9733500
[TBL] [Abstract][Full Text] [Related]
25. Amino-substituted 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H- dibenz[de,h]isoquinoline-1,3-diones. Synthesis, antitumor activity, and quantitative structure--activity relationship.
Sami SM; Dorr RT; Sólyom AM; Alberts DS; Remers WA
J Med Chem; 1995 Mar; 38(6):983-93. PubMed ID: 7699715
[TBL] [Abstract][Full Text] [Related]
26. Anthrapyrazoles, a new class of intercalating agents with high-level, broad spectrum activity against murine tumors.
Leopold WR; Nelson JM; Plowman J; Jackson RC
Cancer Res; 1985 Nov; 45(11 Pt 1):5532-9. PubMed ID: 4053027
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and antileukemic activity of bis[[(carbamoyl)oxy]methyl]- substituted pyrrolo[2,1-a]isoquinolines, pyrrolo[1,2-a]quinolines, pyrrolo[2,1-a]isobenzazepines, and pyrrolo[1,2-a]benzazepines.
Anderson WK; Heider AR; Raju N; Yucht JA
J Med Chem; 1988 Nov; 31(11):2097-102. PubMed ID: 3184121
[TBL] [Abstract][Full Text] [Related]
28. In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride.
Berners-Price SJ; Mirabelli CK; Johnson RK; Mattern MR; McCabe FL; Faucette LF; Sung CM; Mong SM; Sadler PJ; Crooke ST
Cancer Res; 1986 Nov; 46(11):5486-93. PubMed ID: 3756897
[TBL] [Abstract][Full Text] [Related]
29. Structural modification study of mitoxantrone (DHAQ). Chloro-substituted mono- and bis[(aminoalkyl)amino]anthraquinones.
Zee-Cheng RK; Mathew AE; Xu PL; Northcutt RV; Cheng CC
J Med Chem; 1987 Sep; 30(9):1682-6. PubMed ID: 3625713
[TBL] [Abstract][Full Text] [Related]
30. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, chemical reactivity, and antileukemic activity of 5-substituted 6,7-bis(hydroxymethyl)pyrrolo[1,2-c]thiazole biscarbamates and the corresponding sulfoxides and sulfones.
Anderson WK; Mach RH
J Med Chem; 1987 Nov; 30(11):2109-15. PubMed ID: 3669018
[TBL] [Abstract][Full Text] [Related]
32. Chromophore-modified antitumor anthracenediones: synthesis, DNA binding, and cytotoxic activity of 1,4-bis[(aminoalkyl)amino]benzo[g]-phthalazine-5,10-diones.
Gandolfi CA; Beggiolin G; Menta E; Palumbo M; Sissi C; Spinelli S; Johnson F
J Med Chem; 1995 Feb; 38(3):526-36. PubMed ID: 7853345
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and in Vitro cytotoxic activities of 2-alkyl-2,3-dihydro-1H-2,6-diazacyclopenta[b]anthracene-5,10-diones.
Kwak JH; Namgoong K; Jung JK; Han SB; Cho J; Kim HM; Park SG; Lee K; Kang JS; Lee H
Arch Pharm Res; 2010 May; 33(5):663-7. PubMed ID: 20512462
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of N-deacetyl-N-glycosylalkylthiocolchicines as antileukemic agents.
Shiau GT; De KK; Harmon RE
J Pharm Sci; 1978 Mar; 67(3):394-7. PubMed ID: 641731
[TBL] [Abstract][Full Text] [Related]
35. Potential antitumor agents. 50. In vivo solid-tumor activity of derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
Atwell GJ; Rewcastle GW; Baguley BC; Denny WA
J Med Chem; 1987 Apr; 30(4):664-9. PubMed ID: 3560161
[TBL] [Abstract][Full Text] [Related]
36. Antitumor properties of tetrahydrobenz[a]anthraquinone derivatives.
Morreal CE; Bernacki RJ; Hillman M; Atwood A; Cartonia D
J Med Chem; 1990 Feb; 33(2):490-2. PubMed ID: 2299618
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and antitumor evaluation of bis aza-anthracene-9,10-diones and bis aza-anthrapyrazole-6-ones.
Antonini I; Santoni G; Lucciarini R; Amantini C; Dal Ben D; Volpini R; Cristalli G
J Med Chem; 2008 Feb; 51(4):997-1006. PubMed ID: 18232651
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and calculated properties of some 1,4-bis(amino)anthracene-9,10-diones.
Morley JO; Furlong PJ
Org Biomol Chem; 2006 Nov; 4(21):4005-14. PubMed ID: 17047882
[TBL] [Abstract][Full Text] [Related]
39. bis-Mannich bases of styryl ketones as antileukemic agents.
Dimmock JR; Shyam K; Hamon NW; Patil SA; Smith PJ
Neoplasma; 1985; 32(1):85-91. PubMed ID: 3982563
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and antileukemic activity of fluorinated analogues of 2,3-dihydro-5-phenyl-6,7-bis(hydroxymethyl)-1H-pyrrolizine biscarbamate.
Anderson WK; McPherson HL
J Med Chem; 1982 Jan; 25(1):84-6. PubMed ID: 7086826
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
